Neuroprotective Effect of Duloxetine on Chronic Cerebral Hypoperfusion-Induced Hippocampal Neuronal Damage

Overview

Journal Biomol Ther (Seoul)

Specialty Pharmacology

Date 2017 Apr 4

PMID 28365975

Citations 4

Authors

Jin-A Park

Choong-Hyun Lee

Affiliations

Soon will be listed here.

Abstract

Chronic cerebral hypoperfusion (CCH), which is associated with onset of vascular dementia, causes cognitive impairment and neuropathological alterations in the brain. In the present study, we examined the neuroprotective effect of duloxetine (DXT), a potent and balanced serotonin/norepinephrine reuptake inhibitor, on CCH-induced neuronal damage in the hippocampal CA1 region using a rat model of permanent bilateral common carotid arteries occlusion. We found that treatment with 20 mg/kg DXT could attenuate the neuronal damage, the reduction of phosphorylations of mTOR and p70S6K as well as the elevations of TNF-α and IL-1β levels in the hippocampal CA1 region at 28 days following CCH. These results indicate that DXT displays the neuroprotective effect against CCH-induced hippocampal neuronal death, and that neuroprotective effect of DXT may be closely related with the attenuations of CCH-induced decrease of mTOR/p70S6K signaling pathway as well as CCH-induced neuroinflammatory process.

Citing Articles

Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder.

Gao W, Gao Y, Xu Y, Liang J, Sun Y, Zhang Y BMC Psychiatry. 2024; 24(1):449.

PMID: 38877455 PMC: 11179362. DOI: 10.1186/s12888-024-05910-0.

Adalimumab ameliorates memory impairments and neuroinflammation in chronic cerebral hypoperfusion rats.

Xu J, Guo S, Xue R, Xiao L, Kou J, Liu Y Aging (Albany NY). 2021; 13(10):14001-14014.

PMID: 34030135 PMC: 8202885. DOI: 10.18632/aging.203009.

Targeting Pathological Tau by Small Molecule Inhibition of the Poly(A):MSUT2 RNA-Protein Interaction.

Baker J, Uhrich R, Strovas T, Saxton A, Kraemer B ACS Chem Neurosci. 2020; 11(15):2277-2285.

PMID: 32589834 PMC: 8629322. DOI: 10.1021/acschemneuro.0c00214.

Duloxetine Protects Human Neuroblastoma Cells from Oxidative Stress-Induced Cell Death Through Akt/Nrf-2/HO-1 Pathway.

Engel D, de Oliveira J, Lieberknecht V, Severo Rodrigues A, de Bem A, Gabilan N Neurochem Res. 2017; 43(2):387-396.

PMID: 29134401 DOI: 10.1007/s11064-017-2433-3.

References

Jia Y, Jin W, Xiao Y, Dong Y, Wang T, Fan M . Lipoxin A4 methyl ester alleviates vascular cognition impairment by regulating the expression of proteins related to autophagy and ER stress in the rat hippocampus. Cell Mol Biol Lett. 2015; 20(3):475-87. DOI: 10.1515/cmble-2015-0027. View

Yang H, Shi O, Jin Y, Henrich-Noack P, Qiao H, Cai C . Functional protection of learning and memory abilities in rats with vascular dementia. Restor Neurol Neurosci. 2014; 32(5):689-700. DOI: 10.3233/RNN-140409. View

Lee T, Park J, Ahn J, Shin M, Cho J, Bae E . Pretreated duloxetine protects hippocampal CA1 pyramidal neurons from ischemia-reperfusion injury through decreases of glial activation and oxidative stress. J Neurol Sci. 2016; 370:229-236. DOI: 10.1016/j.jns.2016.09.059. View

Koh P, Cho J, Won C, Lee H, Sung J, Kim M . Estradiol attenuates the focal cerebral ischemic injury through mTOR/p70S6 kinase signaling pathway. Neurosci Lett. 2008; 436(1):62-6. DOI: 10.1016/j.neulet.2008.02.061. View

Choi H, Park J, Ahn J, Hong S, Cho J, Won M . The anti-inflammatory activity of duloxetine, a serotonin/norepinephrine reuptake inhibitor, prevents kainic acid-induced hippocampal neuronal death in mice. J Neurol Sci. 2015; 358(1-2):390-7. DOI: 10.1016/j.jns.2015.10.001. View

Janelidze S, Hu B, Siesjo P, Siesjo B . Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia. Neurobiol Dis. 2001; 8(1):147-54. DOI: 10.1006/nbdi.2000.0325. View

Cechetti F, Pagnussat A, Worm P, Elsner V, Ben J, da Costa M . Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res Bull. 2011; 87(1):109-16. DOI: 10.1016/j.brainresbull.2011.10.006. View

Nemeroff C, Schatzberg A, Goldstein D, Detke M, Mallinckrodt C, Lu Y . Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull. 2003; 36(4):106-32. View

Koh P . Ferulic acid attenuates focal cerebral ischemia-induced decreases in p70S6 kinase and S6 phosphorylation. Neurosci Lett. 2013; 555:7-11. DOI: 10.1016/j.neulet.2013.09.001. View

10.

Ueno Y, Koike M, Shimada Y, Shimura H, Hira K, Tanaka R . L-carnitine enhances axonal plasticity and improves white-matter lesions after chronic hypoperfusion in rat brain. J Cereb Blood Flow Metab. 2014; 35(3):382-91. PMC: 4348379. DOI: 10.1038/jcbfm.2014.210. View

11.

Koh P . Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway. Neurosci Lett. 2008; 444(1):74-8. DOI: 10.1016/j.neulet.2008.08.024. View

12.

He X, Wang Y, Bi M, Du G . Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats. Eur J Pharmacol. 2012; 680(1-3):41-8. DOI: 10.1016/j.ejphar.2012.01.025. View

13.

Park J, Lee C . Temporal changes in mammalian target of rapamycin (mTOR) and phosphorylated-mTOR expressions in the hippocampal CA1 region of rat with vascular dementia. J Vet Sci. 2016; 18(1):11-16. PMC: 5366295. DOI: 10.4142/jvs.2017.18.1.11. View

14.

Goldstein D, Lu Y, Detke M, Lee T, Iyengar S . Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005; 116(1-2):109-18. DOI: 10.1016/j.pain.2005.03.029. View

15.

Farkas E, Donka G, de Vos R, Mihaly A, Bari F, Luiten P . Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol. 2004; 108(1):57-64. DOI: 10.1007/s00401-004-0864-9. View

16.

Guay D . Duloxetine for management of stress urinary incontinence. Am J Geriatr Pharmacother. 2005; 3(1):25-38. DOI: 10.1016/j.amjopharm.2005.03.004. View

17.

Lee C, Park J, Ahn J, Won M . Effects of melatonin on cognitive impairment and hippocampal neuronal damage in a rat model of chronic cerebral hypoperfusion. Exp Ther Med. 2016; 11(6):2240-2246. PMC: 4887947. DOI: 10.3892/etm.2016.3216. View

18.

Laplante M, Sabatini D . mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93. PMC: 3331679. DOI: 10.1016/j.cell.2012.03.017. View

19.

Gingras A, Raught B, Sonenberg N . Control of translation by the target of rapamycin proteins. Prog Mol Subcell Biol. 2001; 27:143-74. DOI: 10.1007/978-3-662-09889-9_6. View

20.

Shi G, OuYang Y, Shi J, Liu Y, Yuan W, Jia L . PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway. Biochem Biophys Res Commun. 2010; 404(4):941-5. DOI: 10.1016/j.bbrc.2010.12.085. View